Edition:
United States

Otonomy Inc (OTIC.OQ)

OTIC.OQ on NASDAQ Stock Exchange Global Select Market

2.70USD
21 Sep 2018
Change (% chg)

$0.10 (+3.85%)
Prev Close
$2.60
Open
$2.60
Day's High
$2.70
Day's Low
$2.60
Volume
149,152
Avg. Vol
48,979
52-wk High
$6.40
52-wk Low
$2.50

Chart for

About

Otonomy, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Company's product candidates include OTIPRIO, OTO-104 and OTO-311. OTIPRIO is a single-dose, physician-administered antibacterial, which is used for the treatment... (more)

Overall

Beta: 2.91
Market Cap(Mil.): $82.70
Shares Outstanding(Mil.): 30.63
Dividend: --
Yield (%): --

Financials

  OTIC.OQ Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -2.13 -- --
ROI: -50.86 1.54 12.72
ROE: -51.89 0.30 14.84

BRIEF-Otonomy Qtrly Loss Per Share $0.37

* OTONOMY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 09 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF81.88 -0.06

Earnings vs. Estimates